Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

GZD856

SKU: orb1909901

Description

GZD856 is a novel and orally bioavailable PDGFRα/β inhibitor with IC50s of 68.6 and 136.6 nM, respectively. Anti-lung cancer activities. Also a Bcr-AblT315I inhibitor with IC50s of 19.9 and 15.4 nM for Bcr-Abl and T315I mutant.

Images & Validation

Key Properties

CAS Number1257628-64-0
MW532.559496164322
Purity>98%
FormulaC29H27F3N6O
SMILESFC(C1C=C(C=CC=1CN1CCN(C)CC1)NC(C1C=CC(C)=C(C#CC2C=NC3=CC=NN3C=2)C=1)=O)(F)F

Storage & Handling

Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Similar Products

  • GZD856 formic [orb1685952]

    2804039-78-7

    578.58

    C30H29F3N6O3

    25 mg, 50 mg, 100 mg
  • GZD856 [orb1709507]

    99.64% (May vary between batches)

    1257628-64-0

    532.56

    C29H27F3N6O

    50 mg, 100 mg, 25 mg, 1 mg, 5 mg, 10 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Protocol Information

Available Sizes

Select a size below

100 mg
$ 1,180.00
250 mg
$ 2,100.00
1 g
$ 4,010.00
DispatchUsually dispatched within 5-10 working days
Bulk Enquiry